UK markets close in 5 hours 18 minutes

Supernus Pharmaceuticals, Inc. (SUPN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
30.26+0.31 (+1.04%)
At close: 04:00PM EDT
30.26 0.00 (0.00%)
After hours: 04:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close29.95
Open29.96
Bid30.24 x 100
Ask30.31 x 100
Day's range29.82 - 30.40
52-week range21.99 - 38.09
Volume195,006
Avg. volume389,266
Market cap1.656B
Beta (5Y monthly)0.99
PE ratio (TTM)1,513.00
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Benzinga

    Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease

    On Monday, Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) announced a regulatory update for SPN-830, an investigational apomorphine infusion device under FDA review for the continuous treatment of motor fluctuations (“off” episodes) in Parkinson’s disease (PD). The FDA has issued a Complete Response Letter (CRL) in response to the company’s New Drug Application (NDA) for SPN-830. The CRL indicates that the review cycle for the application is complete but that the application still needs to be prepa

  • Insider Monkey

    11 Best Small Cap Pharma Stocks to Invest In

    In this piece, we will take a look at the 11 best small cap pharma stocks to invest in. If you want to skip our overview of the global pharmaceutical and healthcare industry, which is one the most unique sectors in the world, then you can check out 5 Best Small Cap Pharma Stocks to […]

  • Simply Wall St.

    Supernus Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

    Supernus Pharmaceuticals ( NASDAQ:SUPN ) Full Year 2023 Results Key Financial Results Revenue: US$607.5m (down 8.9...